Cancer immunotherapy trials: Leading a paradigm shift in drug development

Leisha A. Emens; Lisa H. Butterfield; F. Stephen Hodi; Francesco M. Marincola; Howard L. Kaufman

doi:10.1186/s40425-016-0146-9

Cancer immunotherapy trials: Leading a paradigm shift in drug development

Leisha A. Emens, Lisa H. Butterfield, F. Stephen Hodi, Francesco M. Marincola, Howard L. Kaufman

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

24 Scopus citations

Original language	English (US)
Article number	42
Journal	Journal for immunotherapy of cancer
Volume	4
Issue number	1
DOIs	https://doi.org/10.1186/s40425-016-0146-9
State	Published - Jul 19 2016

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Molecular Medicine
Oncology
Pharmacology
Cancer Research

Access to Document

10.1186/s40425-016-0146-9

Cite this

@article{e82d471c2f024f8b8593b1474f797e1d,

title = "Cancer immunotherapy trials: Leading a paradigm shift in drug development",

author = "Emens, {Leisha A.} and Butterfield, {Lisa H.} and Hodi, {F. Stephen} and Marincola, {Francesco M.} and Kaufman, {Howard L.}",

year = "2016",

month = jul,

day = "19",

doi = "10.1186/s40425-016-0146-9",

language = "English (US)",

volume = "4",

journal = "Journal for immunotherapy of cancer",

issn = "2051-1426",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Cancer immunotherapy trials

T2 - Leading a paradigm shift in drug development

AU - Emens, Leisha A.

AU - Butterfield, Lisa H.

AU - Hodi, F. Stephen

AU - Marincola, Francesco M.

AU - Kaufman, Howard L.

PY - 2016/7/19

Y1 - 2016/7/19

UR - http://www.scopus.com/inward/record.url?scp=84997604979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997604979&partnerID=8YFLogxK

U2 - 10.1186/s40425-016-0146-9

DO - 10.1186/s40425-016-0146-9

M3 - Comment/debate

C2 - 27437105

AN - SCOPUS:84997604979

SN - 2051-1426

VL - 4

JO - Journal for immunotherapy of cancer

JF - Journal for immunotherapy of cancer

IS - 1

M1 - 42

ER -

Cancer immunotherapy trials: Leading a paradigm shift in drug development

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this